LINICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 396 JPY | -2.94% |
|
+1.54% | -25.28% |
Valuation
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 30,740 | 18,453 | 17,753 | 20,621 | 15,743 | 8,944 | - | - |
| Enterprise Value (EV) 1 | 30,408 | 17,396 | 17,359 | 18,740 | 12,241 | 5,016 | 4,616 | 4,315 |
| P/E ratio | 54.2 x | 38.2 x | 32.9 x | 26.1 x | 15.7 x | 29.1 x | 29.1 x | 22.4 x |
| Yield | 0.88% | 1.71% | 1.78% | 1.53% | 2.01% | 3.79% | 3.79% | 3.79% |
| Capitalization / Revenue | 2.72 x | 1.69 x | 1.73 x | 1.78 x | 1.26 x | 0.73 x | 0.73 x | 0.69 x |
| EV / Revenue | 2.69 x | 1.59 x | 1.69 x | 1.62 x | 0.98 x | 0.41 x | 0.38 x | 0.33 x |
| EV / EBITDA | 18.3 x | 11.9 x | 19.8 x | 12.3 x | 6.97 x | 4.37 x | 4.48 x | 3.51 x |
| EV / FCF | -31.2 x | 38.6 x | -316 x | 12.1 x | 6.92 x | 5.73 x | 6.6 x | 7.45 x |
| FCF Yield | -3.21% | 2.59% | -0.32% | 8.29% | 14.5% | 17.4% | 15.1% | 13.4% |
| Price to Book | 5.85 x | 3.46 x | 3.11 x | 3.15 x | 2.08 x | 1.18 x | 1.18 x | 1.14 x |
| Nbr of stocks (in thousands) | 22,587 | 22,587 | 22,586 | 22,586 | 22,586 | 22,586 | - | - |
| Reference price 2 | 1,361 | 817.0 | 786.0 | 913.0 | 697.0 | 396.0 | 396.0 | 396.0 |
| Announcement Date | 5/15/19 | 5/25/20 | 5/14/21 | 5/16/22 | 5/15/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 11,313 | 10,935 | 10,279 | 11,555 | 12,517 | 12,280 | 12,300 | 12,900 |
| EBITDA 1 | 1,660 | 1,464 | 876.3 | 1,526 | 1,757 | 1,147 | 1,030 | 1,230 |
| EBIT 1 | 1,212 | 1,005 | 453 | 1,086 | 1,257 | 717 | 600 | 800 |
| Operating Margin | 10.71% | 9.19% | 4.41% | 9.4% | 10.04% | 5.84% | 4.88% | 6.2% |
| Earnings before Tax (EBT) 1 | 1,164 | 808 | 358 | 1,032 | 1,379 | 684 | 550 | 750 |
| Net income 1 | 568 | 482 | 539 | 790.5 | 1,004 | 307 | 400 | 540 |
| Net margin | 5.02% | 4.41% | 5.24% | 6.84% | 8.02% | 2.5% | 3.25% | 4.19% |
| EPS 2 | 25.09 | 21.38 | 23.91 | 35.00 | 44.47 | 13.60 | 13.60 | 17.70 |
| Free Cash Flow 1 | -976 | 451 | -55 | 1,554 | 1,770 | 875 | 699 | 579 |
| FCF margin | -8.63% | 4.12% | -0.54% | 13.45% | 14.14% | 7.13% | 5.68% | 4.49% |
| FCF Conversion (EBITDA) | - | 30.8% | - | 101.8% | 100.76% | 76.29% | 67.86% | 47.07% |
| FCF Conversion (Net income) | - | 93.57% | - | 196.59% | 176.23% | 285.02% | 174.75% | 107.22% |
| Dividend per Share 2 | 12.00 | 14.00 | 14.00 | 14.00 | 14.00 | 15.00 | 15.00 | 15.00 |
| Announcement Date | 5/15/19 | 5/25/20 | 5/14/21 | 5/16/22 | 5/15/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,389 | 4,981 | 2,738 | 5,522 | 3,091 | 2,941 | 2,868 | 3,052 | 5,921 | 3,327 | 3,270 | 3,082 | 2,982 | 6,064 | 3,184 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 571 | 185 | 361.9 | 507.7 | 329 | 249.2 | -26 | 400.2 | 373.4 | 367.3 | 516.4 | 112.1 | 309.2 | 421.2 | 220 |
| Operating Margin | 10.6% | 3.71% | 13.22% | 9.19% | 10.64% | 8.47% | -0.91% | 13.12% | 6.31% | 11.04% | 15.79% | 3.64% | 10.37% | 6.95% | 6.91% |
| Earnings before Tax (EBT) 1 | 429 | 77 | 293.7 | 388 | 382 | - | 139 | - | 678 | 144 | - | 64 | - | 374 | 146 |
| Net income 1 | 230 | -13 | 185 | 252.6 | 272.3 | 265.6 | 76 | 391.9 | 468.8 | 110 | 426.8 | 3.532 | 175.4 | 178.9 | 74.64 |
| Net margin | 4.27% | -0.26% | 6.76% | 4.57% | 8.81% | 9.03% | 2.65% | 12.84% | 7.92% | 3.31% | 13.05% | 0.11% | 5.88% | 2.95% | 2.34% |
| EPS 2 | 10.20 | -0.6100 | 8.000 | 11.18 | 12.06 | - | 3.410 | - | 20.76 | 4.810 | - | 0.1600 | - | 7.920 | 3.310 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/14/19 | 11/13/20 | 11/12/21 | 11/12/21 | 2/14/22 | 5/16/22 | 8/12/22 | 11/14/22 | 11/14/22 | 2/14/23 | 5/15/23 | 8/14/23 | 11/14/23 | 11/14/23 | 2/14/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 332 | 1,057 | 394 | 1,881 | 3,502 | 3,928 | 4,328 | 4,629 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -976 | 451 | -55 | 1,554 | 1,770 | 875 | 699 | 579 |
| ROE (net income / shareholders' equity) | 10.9% | 9.1% | 9.8% | 12.9% | 14.2% | 4.1% | 5.3% | 7% |
| ROA (Net income/ Total Assets) | 11.1% | 6.67% | 3.98% | 7.63% | 7.73% | 4.6% | 3.4% | 4.5% |
| Assets 1 | 5,101 | 7,224 | 13,539 | 10,356 | 12,987 | 6,674 | 11,765 | 12,000 |
| Book Value Per Share 2 | 232.0 | 236.0 | 253.0 | 290.0 | 336.0 | 334.0 | 337.0 | 346.0 |
| Cash Flow per Share | 30.90 | 29.40 | 32.70 | 43.20 | 52.60 | - | - | - |
| Capex 1 | 180 | 741 | 78 | 77 | 69 | 100 | 100 | 100 |
| Capex / Sales | 1.59% | 6.78% | 0.76% | 0.67% | 0.55% | 0.81% | 0.81% | 0.78% |
| Announcement Date | 5/15/19 | 5/25/20 | 5/14/21 | 5/16/22 | 5/15/23 | - | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
396
JPY
Average target price
500
JPY
Spread / Average Target
+26.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.28% | 56.82M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 2183 Stock
- Financials Linical Co., Ltd.
